Catalent, Inc.

NYSE:CTLT

59.41 (USD) • At close November 8, 2024
Bedrijfsnaam Catalent, Inc.
Symbool CTLT
Munteenheid USD
Prijs 59.41
Beurswaarde 10,783,627,920
Dividendpercentage 0%
52-weken bereik 32.38 - 61.2
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Alessandro Maselli
Website https://www.catalent.com

An error occurred while fetching data.

Over Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development,

Vergelijkbare Aandelen

The Cooper Companies, Inc. logo

The Cooper Companies, Inc.

COO

103.75 USD

Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated

DGX

159.37 USD

Molina Healthcare, Inc. logo

Molina Healthcare, Inc.

MOH

329.65 USD

Waters Corporation logo

Waters Corporation

WAT

384.51 USD

Cardinal Health, Inc. logo

Cardinal Health, Inc.

CAH

120.56 USD

Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.

BIO-B

301 USD

Teleflex Incorporated logo

Teleflex Incorporated

TFX

195.55 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)